PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsViaject
Viaject
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
7731 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Type 2 diabetes mellitusD003924EFO_0001360E11199653122144
Diabetes mellitusD003920EFO_0000400E08-E1310944211699
Type 1 diabetes mellitusD003922EFO_0001359E103092121474
Insulin resistanceD007333EFO_0002614E88.8193115313
HyperglycemiaD006943R73.913315
Metabolic diseasesD008659EFO_0000589E88.9314
SchizophreniaD012559EFO_0000692F2044
Metabolic syndromeD024821EFO_0000195E88.810213
Gestational diabetesD016640O24.411
Myocardial infarctionD009203EFO_0000612I2111
Show 2 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C80336
Colorectal neoplasmsD01517911
Colonic neoplasmsD003110C1811
Rectal neoplasmsD01200411
Head and neck neoplasmsD00625811
Squamous cell carcinoma of head and neckD00007719511
HyperinsulinismD006946E16.111
CarcinomaD002277C80.011
Neuroendocrine tumorsD018358EFO_1001901D3A.811
Neoplasm metastasisD009362EFO_000970811
Show 2 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients23124
Glycemic controlD00008500211
AggressionD000374EFO_000301511
Motor activityD009043EFO_000394011
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prediabetic stateD011236EFO_1001121R73.0333
Disease progressionD01845011
PancreatitisD010195EFO_0000278K8511
Patient participationD01035811
Diabetic neuropathiesD003929EFO_100078311
Glucose intoleranceD018149HP_0000833R73.0311
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use